Silver Book Fact

AFib, an economic burden

Fact image

AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.

Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2). http://www.ncbi.nlm.nih.gov/pubmed/19450086

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 2006; 9(5). http://www.ncbi.nlm.nih.gov/pubmed/16961553

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource
Title
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Publication
Value in Health
Publication Date
2006
Volume & Issue
Volume 9, Issue 5
Pages
348-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Heart failure in people with AFib
    AFib can also lead to heart failure. Within the first year of diagnosis, AFib patients have a 36.7% chance of experiencing heart failure– compared to 10.4% in those without AFib.  
  • Depression and anxiety in AFib patients
    Around 1/3 of atrial fibrillation patients have elevated levels of depression and anxiety.  
  • Atrial Fibrillation is Increasingly Prevalent in the United States
    Atrial Fibrillation is Increasingly Prevalent in the United States  
  • Medical service utilization in AFib
    Medical service utilization in persons with and without atrial fibrillation  
  • Lifetime risk of atrial fibrillation
    At age 80, the remaining lifetime risk of atrial fibrillation is around 22%.